Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Engineering × 90 days × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

NET 1 Endocrine 1

Conditions

Neuroendocrine Tumors 1

Interventions

Specimen Handling 116 pembrolizumab 113 Cyclophosphamide 98 Magnetic Resonance Spectroscopy 91 Biopsy 87 fludarabine 74 Nivolumab 53 venetoclax 48 Radiotherapy 34 Cetuximab 33 Carboplatin 33 fludarabine phosphate 32 Paclitaxel 31 Gemcitabine 31 Bevacizumab 31 Cisplatin 30 atezolizumab 28 Fluorouracil 28 Azacitidine 28 Cytarabine 25 durvalumab 24 Ipilimumab 24 Injections 24 Dexamethasone 24 Radiosurgery 23 Lenalidomide 23 Temozolomide 22 Oxaliplatin 22 Irinotecan 21 Leucovorin 20

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07366658 2026-01-26

NEUK203-13

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Phase 1 Not yet recruiting

Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡